text: In the United States, drug costs are partially unregulated, but instead are the result of negotiations between drug companies and insurance companies.
  High prices have been attributed to monopolies given to manufacturers by the government. New drug development costs continue to rise as well. Despite the enormous advances in science and technology, the number of new blockbuster drugs approved by the government per billion dollars spent has halved every 9 years since 1950.